Literature DB >> 8012880

Canadian Consensus Conference on Coronary Thrombolysis--1994 recommendations. National Health Research and Development Program.

.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 8012880

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  5 in total

1.  Observer variability in ECG interpretation for thrombolysis eligibility: experience and context matter.

Authors:  David Massel
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

Review 2.  Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction.

Authors:  S Noble; D McTavish
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 3.  Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction.

Authors:  L B Barradell; K L Goa
Journal:  Pharmacoeconomics       Date:  1995-11       Impact factor: 4.981

4.  Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction.

Authors:  J M Boucher; N Racine; T H Thanh; E Rahme; J Brophy; J LeLorier; P Théroux
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

5.  Differences in access to coronary care unit among patients with acute myocardial infarction in Rome: old, ill, and poor people hold the burden of inefficiency.

Authors:  Carla Ancona; Massimo Arcà; Carlo Saitto; Nera Agabiti; Danilo Fusco; Valeria Tancioni; Carlo A Perucci
Journal:  BMC Health Serv Res       Date:  2004-12-09       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.